
zzso zzso is the favored therapy in childhood immune zzso zzso It is usually well tolerated with manageable side effects, but zzso and zzso zzso following its administration have been zzso mostly in zzso 

We describe a 3-year-old girl with immune zzso zzso and zzso zzso who received intravenous zzso therapy and subsequently developed zzso cerebral zzso 

zzso specific as well as other factors may play a role in the development of this complication of intravenous zzso zzso This is the only reported case of intravenous zzso zzso in a child with immune zzso zzso and zzso zzso 

zzso complications are associated with intravenous zzso administration and this includes cerebral zzso 

